Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery Disease

Cleerly, Inc., a digital healthcare company focused on AI-driven heart disease diagnosis, has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online in the European Heart Journal Cardiovascular Imaging.

Related Keywords

Washington ,United States ,Spain ,Barcelona ,Comunidad Autonoma De Cataluna ,Boston ,Massachusetts ,Jamesp Earls ,James Earls ,Gonzalez Quesada ,Udo Hoffman ,Society Of Cardiovascular Computed Tomography ,European Heart Journal Cv Imag ,Radiology At George Washington University ,Late Breaking Clinical Research ,American Society Of Cardiac Imaging ,Cleerly Inc ,Fellows Of The Society Cardiovascular ,European Association Of Cardiovascular Imaging ,European Heart Journal Cardiovascular ,Diagnostic Certainty ,Downstream Testing ,Coronary Revascularization ,Medical Therapy ,Chief Medical Officer ,George Washington University ,Medical Director ,Vice President ,Fairfax Radiological Consultants ,International Society ,Magnetic Resonance ,North American Society ,Cardiac Imaging ,Cardiovascular Computed Tomography ,Press European Heart Journal ,James Min ,American College ,Cardiology Annual Scientific Meeting New Orleans ,Prognostic Assessment ,Based Algorithm ,Coronary Ischemia ,European Association ,Cardiovascular Imaging ,Per Vessel Prediction ,Plaque Features Associated ,Comparison With Myocardial Perfusion Imaging ,Obstructive Stenosis Using Invasive Angiography ,Suspected Coronary Artery ,Eur Heartj Cardiovasc ,